Cengild Medical Berhad (KLSE:CENGILD)
Malaysia
· Delayed Price · Currency is MYR 0.2300
-0.0050 (-2.13%)
At close: Jul 3, 2025
Cengild Medical Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2018 - 2019 |
| 77.14 | 66.85 | 70.28 | 64.44 | 63.47 | 39.18 | Upgrade
| |
Revenue Growth (YoY) | 16.03% | -4.88% | 9.06% | 1.53% | 62.00% | 39.02% | Upgrade
|
Cost of Revenue | 41.84 | 35.76 | 39.55 | 38.39 | 36.79 | 21.67 | Upgrade
|
Gross Profit | 35.3 | 31.09 | 30.73 | 26.05 | 26.68 | 17.51 | Upgrade
|
Selling, General & Admin | 23.67 | 18.76 | 16.24 | 14.48 | 12.21 | 10.48 | Upgrade
|
Other Operating Expenses | 0.24 | - | - | - | - | 0.01 | Upgrade
|
Operating Expenses | 23.91 | 18.76 | 16.26 | 14.48 | 12.21 | 10.49 | Upgrade
|
Operating Income | 11.4 | 12.33 | 14.46 | 11.57 | 14.47 | 7.02 | Upgrade
|
Interest Expense | -0.37 | -0.63 | -0.73 | -0.85 | -1.22 | -1.58 | Upgrade
|
Earnings From Equity Investments | 0.15 | -0.35 | - | - | -0 | - | Upgrade
|
Other Non Operating Income (Expenses) | 4.49 | 4.49 | 3.65 | 1.39 | 0.22 | - | Upgrade
|
EBT Excluding Unusual Items | 15.67 | 15.84 | 17.37 | 12.11 | 13.47 | 5.44 | Upgrade
|
Other Unusual Items | - | - | - | - | - | 0.1 | Upgrade
|
Pretax Income | 15.67 | 15.84 | 17.37 | 12.11 | 13.47 | 5.53 | Upgrade
|
Income Tax Expense | 5.3 | 4.77 | 4.09 | 2.72 | 3.46 | 1.58 | Upgrade
|
Net Income | 10.37 | 11.08 | 13.29 | 9.39 | 10 | 3.95 | Upgrade
|
Net Income to Common | 10.37 | 11.08 | 13.29 | 9.39 | 10 | 3.95 | Upgrade
|
Net Income Growth | -12.16% | -16.64% | 41.50% | -6.13% | 153.15% | 167.66% | Upgrade
|
Shares Outstanding (Basic) | 833 | 833 | 819 | 644 | 600 | 13 | Upgrade
|
Shares Outstanding (Diluted) | 833 | 834 | 826 | 645 | 600 | 13 | Upgrade
|
Shares Change (YoY) | 0.13% | 1.00% | 27.94% | 7.56% | 4700.00% | - | Upgrade
|
EPS (Basic) | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.32 | Upgrade
|
EPS (Diluted) | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.32 | Upgrade
|
EPS Growth | -12.74% | -17.39% | 10.46% | -12.59% | -94.73% | 167.66% | Upgrade
|
Free Cash Flow | -18.48 | -2.8 | 11.78 | 14.9 | 12.6 | 10.63 | Upgrade
|
Free Cash Flow Per Share | -0.02 | -0.00 | 0.01 | 0.02 | 0.02 | 0.85 | Upgrade
|
Dividend Per Share | 0.010 | 0.007 | 0.007 | 0.004 | - | - | Upgrade
|
Dividend Growth | 31.08% | - | 100.00% | - | - | - | Upgrade
|
Gross Margin | 45.77% | 46.51% | 43.72% | 40.42% | 42.03% | 44.70% | Upgrade
|
Operating Margin | 14.77% | 18.45% | 20.58% | 17.95% | 22.79% | 17.92% | Upgrade
|
Profit Margin | 13.44% | 16.57% | 18.91% | 14.57% | 15.76% | 10.09% | Upgrade
|
Free Cash Flow Margin | -23.96% | -4.19% | 16.77% | 23.12% | 19.85% | 27.13% | Upgrade
|
EBITDA | 16.29 | 14.88 | 16.33 | 14.56 | 17.56 | 9.92 | Upgrade
|
EBITDA Margin | 21.12% | 22.26% | 23.23% | 22.60% | 27.67% | 25.33% | Upgrade
|
D&A For EBITDA | 4.9 | 2.55 | 1.87 | 2.99 | 3.1 | 2.9 | Upgrade
|
EBIT | 11.4 | 12.33 | 14.46 | 11.57 | 14.47 | 7.02 | Upgrade
|
EBIT Margin | 14.77% | 18.45% | 20.58% | 17.95% | 22.79% | 17.92% | Upgrade
|
Effective Tax Rate | 33.84% | 30.08% | 23.52% | 22.48% | 25.72% | 28.59% | Upgrade
|
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.